Updated on 22 November 2013
Over the last several years, BRF has been tracking various emerging sciences and noticed an explosive growth in the field of molecular imaging, a discipline at the intersection of molecular biology and in vivo imaging, thus allowing the visualization of any cellular function and molecular processes. BRF also recognized an ever-growing role of molecular imaging in drug development and translational medical research. The ability to image fine molecular changes offers an incredible number of exciting possibilities for health care including early detection, diagnosis, and even treatment of disease.
BRF envisioned an opportunity to leverage its existing imaging and radiochemistry expertise to establish a Molecular Imaging Center that creates a unique national resource located in Shreveport. According to Dr John George, president and CEO, BRF, "We are very fortunate to have recruited Drs. Pradeep and Sudha Garg to lead the establishment of the Center for Molecular Imaging and Therapy. Their stellar research and clinical resumes, as well as their past success at previous institutions, make this an exciting opportunity for our community, state and region."